| |
| |
|
| Insider
Information: |
Hastings Paul J |
| Relationship: |
|
| City: |
|
| State: |
|
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
5 |
|
| Direct
Shares |
258,381 |
|
|
Indirect Shares
|
6,636 |
|
|
| Direct
Value |
$227,156 |
|
|
|
Indirect Value
|
$19,410 |
|
|
| Total
Shares |
265,017 |
|
|
| Total
Value |
$246,567 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
6
|
|
Stock
price went up :
|
0
|
1
|
| Stock
price went down : |
0
|
5
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -131.8%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Novelion Therapeutics Inc |
NVLN |
President & CEO, Direc... |
2005-04-29 |
9,500 |
|
0 |
Premium* |
|
|
Pacira Pharmaceuticals, Inc. |
PCRX |
Director |
2023-06-14 |
8,374 |
2013-05-15 |
0 |
Premium* |
|
|
Relypsa Inc |
RLYP |
Director |
2016-09-01 |
0 |
2014-06-19 |
0 |
Premium* |
|
|
Protara Therapeutics, Inc |
TARA |
Director |
|
0 |
2016-10-18 |
6,636 |
Premium* |
|
|
Nkarta, Inc. |
NKTX |
|
2024-03-04 |
240,507 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
62 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| NVLN |
Novelion Therapeutics Inc |
President & CEOOfficer |
• • – |
2004-11-19 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
8,600 |
|
- |
|
| TARA |
Protara Therapeutics, Inc |
Director |
– • – |
2016-10-18 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
6,636 |
|
- |
|
| NKTX |
Nkarta, Inc. |
See RemarksOfficer |
• • – |
2020-07-09 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
253,061 |
|
- |
|
| RLYP |
Relypsa Inc |
Director |
– • – |
2014-06-19 |
4 |
A |
$0.00 |
$0 |
D/D |
2,712 |
2,712 |
0 |
- |
|
| PCRX |
Pacira Pharmaceuticals, I... |
Director |
– • – |
2015-06-03 |
4 |
A |
$0.00 |
$0 |
D/D |
2,000 |
2,853 |
0 |
- |
|
| RLYP |
Relypsa Inc |
Director |
– • – |
2015-06-04 |
4 |
A |
$0.00 |
$0 |
D/D |
2,250 |
4,962 |
0 |
- |
|
| PCRX |
Pacira Pharmaceuticals, I... |
Director |
– • – |
2016-06-15 |
4 |
A |
$0.00 |
$0 |
D/D |
1,488 |
3,205 |
0 |
- |
|
| RLYP |
Relypsa Inc |
Director |
– • – |
2016-06-21 |
4 |
A |
$0.00 |
$0 |
D/D |
2,250 |
4,745 |
0 |
- |
|
| PCRX |
Pacira Pharmaceuticals, I... |
Director |
– • – |
2017-06-14 |
4 |
A |
$0.00 |
$0 |
D/D |
1,357 |
4,562 |
0 |
- |
|
| PCRX |
Pacira Pharmaceuticals, I... |
Director |
– • – |
2018-06-13 |
4 |
A |
$0.00 |
$0 |
D/D |
782 |
3,529 |
0 |
- |
|
| PCRX |
Pacira Pharmaceuticals, I... |
Director |
– • – |
2019-06-05 |
4 |
A |
$0.00 |
$0 |
D/D |
4,134 |
6,881 |
0 |
- |
|
| PCRX |
Pacira Pharmaceuticals, I... |
Director |
– • – |
2020-06-09 |
4 |
A |
$0.00 |
$0 |
D/D |
1,260 |
6,116 |
0 |
- |
|
| PCRX |
Pacira Pharmaceuticals, I... |
Director |
– • – |
2021-06-09 |
4 |
A |
$0.00 |
$0 |
D/D |
1,066 |
6,552 |
0 |
- |
|
| NKTX |
Nkarta, Inc. |
Chief Executive Officer |
• • – |
2022-01-14 |
4 |
A |
$0.00 |
$0 |
D/D |
41,900 |
260,961 |
0 |
- |
|
| PCRX |
Pacira Pharmaceuticals, I... |
Director |
– • – |
2022-06-08 |
4 |
A |
$0.00 |
$0 |
D/D |
1,160 |
7,712 |
0 |
- |
|
| NKTX |
Nkarta, Inc. |
Chief Executive Officer |
• • – |
2022-06-17 |
4 |
A |
$0.00 |
$0 |
D/D |
19,500 |
280,461 |
0 |
- |
|
| NKTX |
Nkarta, Inc. |
Chief Executive Officer |
• • – |
2023-01-13 |
4 |
A |
$0.00 |
$0 |
D/D |
64,500 |
316,797 |
0 |
- |
|
| PCRX |
Pacira Pharmaceuticals, I... |
Director |
– • – |
2023-06-14 |
4 |
A |
$0.00 |
$0 |
D/D |
1,775 |
8,374 |
0 |
- |
|
| NKTX |
Nkarta, Inc. |
Chief Executive Officer |
• • – |
2024-01-04 |
4 |
A |
$0.00 |
$0 |
D/D |
85,000 |
400,204 |
0 |
- |
|
| NKTX |
Nkarta, Inc. |
Chief Executive Officer |
• • – |
2022-09-29 |
4 |
AS |
$13.00 |
$6,474 |
D/D |
(498) |
250,461 |
0 |
- |
|
| NKTX |
Nkarta, Inc. |
Chief Executive Officer |
• • – |
2023-06-20 |
4 |
S |
$4.85 |
$8,264 |
D/D |
(1,704) |
313,402 |
0 |
- |
|
| NVLN |
Novelion Therapeutics Inc |
President & CEO |
• • – |
2005-04-29 |
4 |
B |
$10.77 |
$9,693 |
D/D |
900 |
9,500 |
2.81 |
- |
|
| RLYP |
Relypsa Inc |
Director |
– • – |
2016-06-07 |
4 |
S |
$19.32 |
$19,573 |
D/D |
(1,013) |
2,495 |
0 |
- |
|
| NKTX |
Nkarta, Inc. |
Chief Executive Officer |
• • – |
2023-01-17 |
4 |
S |
$5.49 |
$20,264 |
D/D |
(3,691) |
313,106 |
0 |
- |
|
| PCRX |
Pacira Pharmaceuticals, I... |
Director |
– • – |
2023-06-05 |
4 |
S |
$38.34 |
$22,237 |
D/D |
(580) |
6,599 |
0 |
% |
|
62 Records found
|
|
Page 1 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
